Hemodynamic effects of verapamil in left ventricular valvular volume overload

Insights

Intravenous verapamil improved cardiac function in patients with aortic and mitral insufficiency by reducing vascular resistance. Its vasodilatory effects outweighed negative inotropic effects, suggesting potential therapeutic benefits.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Aortic and mitral insufficiency can be complicated by high systemic vascular resistance.
  • Calcium channel blockers are known to reduce systemic vascular resistance.

Purpose of the Study:

  • To evaluate the effects of intravenous verapamil on hemodynamics in patients with aortic and mitral insufficiency.
  • To determine if verapamil's vasodilatory effects outweigh its negative inotropic effects in these conditions.

Main Methods:

  • Intravenous verapamil was administered to 23 patients (11 with aortic insufficiency, 12 with mitral insufficiency).
  • Hemodynamic parameters including cardiac index, forward stroke volume index, and regurgitant fraction were measured.
  • Left ventricular stress and contractile performance measures were assessed.

Main Results:

  • Verapamil increased cardiac index and forward stroke volume index in both groups.
  • Regurgitant fraction significantly decreased in patients with both aortic and mitral insufficiency.
  • Left ventricular end-systolic stress decreased in both groups; end-diastolic stress decreased in the mitral insufficiency group.
  • No significant change in contractile performance was observed, but end-systolic stress-to-volume index ratio fell in the mitral insufficiency group.

Conclusions:

  • The vasodilatory effects of intravenous verapamil appear to predominate over negative inotropic effects in patients with aortic and mitral insufficiency.
  • Verapamil may be a valuable option for patients intolerant to other vasodilators, those with concurrent ischemic heart disease, or supraventricular arrhythmias.

Related Concept Videos

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...